# Conference Posters for Review

July 25, 2025

Our scientific team is often invited to present posters at a range of academic, pharma, and clinical research conferences focused on neuroscience and mental and brain health.

If you have not been able to meet them in person and see our technical information firsthand, here are some recent posters for review, linked below:

- [SOBP, April 2025](https://drive.google.com/file/d/12FdC4R9RsZzeS-dofw7Q_V-7TJJkRvFe/view?usp=sharing)
- [APA Mental Health Conference, September 2024](https://drive.google.com/file/d/1-C6QFuw4FOQab9BW5dGouvNkgNfm2wEm/view?usp=sharing)
- [AMSUS, February 2024](https://drive.google.com/file/d/1qdeCC6OLXGxwUH7iRJs6I7NYwz6wkHb7/view?usp=sharing)
- [Defense Tech, November 2023](https://drive.google.com/file/d/1LW-fDZT_hbBOLF6biPbgRuWsHWdrZscm/view?usp=sharing)

## Press Contact

Jen Williams

[jen@polarisgenomics.com](mailto:jen@polarisgenomics.com)

+1 802 355 5072

## Additional Reading

### [Our Call to Serve: We’re Veterans Mapping the Biology of Mental Health](https://polarisgenomics.com/our-call-to-serve-were-veterans-mapping-the-biology-of-mental-health/)

November 11, 2025

https://youtu.be/LoiE2KJtNoc On Veterans Day and always, we honor those who have served. As a veteran-owned business, our founding mission of improving the lives of service members and veterans remains at our roots.

### [Polaris Genomics Advances Mental Health Biomarker Discovery](https://polarisgenomics.com/polaris-genomics-advances-mental-health-biomarker-discovery/)

September 16, 2025

For decades, psychiatry has struggled with a critical gap: unlike cardiology or oncology, there are no molecular biomarkers to guide diagnosis or treatment. Polaris Genomics was founded to change that, and our mission recently earned global recognition as we progress...

### [Redefining how mental health is understood and treated](https://polarisgenomics.com/redefining-how-mental-health-is-understood-and-treated/)

June 30, 2025

I’m Sudhama Swamy, Director of Strategic Partnerships & Business Development. Thank you for taking a few minutes to hear from me. This message is especially relevant if you’re: A pharmaceutical company developing therapies for neuropsychiatric conditions such as...